5-ARIs May Protect Against Bladder Cancer Progression
5α-reductase inhibitors are widely used to treat lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH).
In less than 3 months after procedure, only mild urinary symptoms reported; benefits persisted through 6 years
Average video score was 6.65; only 24.3% of videos emphasized critical steps of surgery
Association especially strong among the elderly male population
TG/HDL-C and TC/HDL-C ratios associated with BPH; TG/HDL-C may be risk factor for BPH with normal TG, HDL-C
But rate of retrograde ejaculation higher following many surgical procedures for benign prostatic hyperplasia